Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellinger

Showing results (841-850 of 862) with videos related to

Pageof 87
Sort By:
SLAS Discovery : Advancing Life Sciences R & D|January 9, 2019
EU-OPENSCREEN: A Novel Collaborative Approach to Facilitate Chemical BiologyPhilip Brennecke, Dace Rasina, Oscar Aubi, et al.
JACC. Basic to Translational Science|January 16, 2026
Activating PRKG1 Variant Enhances Smooth Muscle Cell Deformability To Cause AortopathyMarie E Jost, Moyra Schweizer, Philipp Henning, et al.
ACS Omega|October 7, 2017
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit <i>Trypanosoma brucei</i> Pteridine Reductase in Support of Early-Stage Drug DiscoveryPasquale Linciano, Alice Dawson, Ina Pöhner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2024
<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial CancerNiklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, et al.
Scientific Reports|February 9, 2017
ISL1 is a major susceptibility gene for classic bladder exstrophy and a regulator of urinary tract developmentRong Zhang, Michael Knapp, Kentaro Suzuki, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 21, 2019
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery PlatformCarolina B Moraes, Gesa Witt, Maria Kuzikov, et al.
Archives of Toxicology|June 29, 2019
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrationsWiebke Albrecht, Franziska Kappenberg, Tim Brecklinghaus, et al.
The Lancet. Oncology|June 27, 2024
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trialSelim Corbacioglu, Holger Lode, Susanne Ellinger, et al.
IEEE Transactions on Medical Imaging|June 4, 2021
MoNuSAC2020: A Multi-Organ Nuclei Segmentation and Classification ChallengeRuchika Verma, Neeraj Kumar, Abhijeet Patil, et al.
IEEE Transactions on Medical Imaging|October 25, 2019
A Multi-Organ Nucleus Segmentation ChallengeNeeraj Kumar, Ruchika Verma, Deepak Anand, et al.
Pageof 87

Showing results (841-850 of 862) with videos related to

Sort By:
Pageof 87
SLAS Discovery : Advancing Life Sciences R & D|January 9, 2019
EU-OPENSCREEN: A Novel Collaborative Approach to Facilitate Chemical BiologyPhilip Brennecke, Dace Rasina, Oscar Aubi, et al.
JACC. Basic to Translational Science|January 16, 2026
Activating PRKG1 Variant Enhances Smooth Muscle Cell Deformability To Cause AortopathyMarie E Jost, Moyra Schweizer, Philipp Henning, et al.
ACS Omega|October 7, 2017
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit <i>Trypanosoma brucei</i> Pteridine Reductase in Support of Early-Stage Drug DiscoveryPasquale Linciano, Alice Dawson, Ina Pöhner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2024
<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial CancerNiklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, et al.
Scientific Reports|February 9, 2017
ISL1 is a major susceptibility gene for classic bladder exstrophy and a regulator of urinary tract developmentRong Zhang, Michael Knapp, Kentaro Suzuki, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 21, 2019
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery PlatformCarolina B Moraes, Gesa Witt, Maria Kuzikov, et al.
Archives of Toxicology|June 29, 2019
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrationsWiebke Albrecht, Franziska Kappenberg, Tim Brecklinghaus, et al.
The Lancet. Oncology|June 27, 2024
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trialSelim Corbacioglu, Holger Lode, Susanne Ellinger, et al.
IEEE Transactions on Medical Imaging|June 4, 2021
MoNuSAC2020: A Multi-Organ Nuclei Segmentation and Classification ChallengeRuchika Verma, Neeraj Kumar, Abhijeet Patil, et al.
IEEE Transactions on Medical Imaging|October 25, 2019
A Multi-Organ Nucleus Segmentation ChallengeNeeraj Kumar, Ruchika Verma, Deepak Anand, et al.
Pageof 87